AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Visa
V
|
+$576M |
| 2 |
SVNA
7 Acquisition Corporation Class A Ordinary Shares
SVNA
|
+$493M |
| 3 |
Align Technology
ALGN
|
+$446M |
| 4 |
Qualcomm
QCOM
|
+$354M |
| 5 |
PTC
PTC
|
+$307M |
Top Sells
| 1 |
Apple
AAPL
|
+$338M |
| 2 |
Chegg
CHGG
|
+$289M |
| 3 |
Nike
NKE
|
+$270M |
| 4 |
Electronic Arts
EA
|
+$255M |
| 5 |
Sherwin-Williams
SHW
|
+$253M |
Sector Composition
| 1 | Technology | 24.8% |
| 2 | Healthcare | 15.7% |
| 3 | Consumer Discretionary | 12.84% |
| 4 | Financials | 12.03% |
| 5 | Communication Services | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Mersana Therapeutics
MRSN
$38.1M
| $480K | ﹤0.01% |
3,084
+204
| +7% | +$31.8K |
|
2752
Personalis
PSNL
$489M
| $478K | ﹤0.01% |
33,500
| – | – |
|
|
VXRT
2753
DELISTED
Vaxart
VXRT
| $477K | ﹤0.01% |
76,100
-30,300
| -28% | -$190K |
|
|
CMRX
2754
DELISTED
Chimerix, Inc.
CMRX
| $476K | ﹤0.01% |
74,000
| – | – |
|
2755
Pan American Silver
PAAS
$15.1B
| $475K | ﹤0.01% |
19,021
-834
| -4% | -$20.8K |
|
2756
Stoke Therapeutics
STOK
$1.2B
| $475K | ﹤0.01% |
19,800
+1,200
| +6% | +$28.8K |
|
2757
Aclaris Therapeutics
ACRS
$227M
| $474K | ﹤0.01% |
32,600
+4,800
| +17% | +$69.8K |
|
|
AGEN
2758
Agenus
AGEN
$155M
| $471K | ﹤0.01% |
7,459
| – | – |
|
|
DBD
2759
DELISTED
Diebold Nixdorf Incorporated
DBD
| $471K | ﹤0.01% |
52,001
+121
| +0.2% | +$1.1K |
|
2760
Upland Software
UPLD
$67.9M
| $470K | ﹤0.01% |
26,200
| – | – |
|
2761
Utah Medical Products
UTMD
$198M
| $470K | ﹤0.01% |
4,700
| – | – |
|
|
FMTX
2762
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $469K | ﹤0.01% |
33,000
+3,000
| +10% | +$42.6K |
|
2763
Workhorse Group
WKHS
$17.5M
| $467K | ﹤0.01% |
429
| – | – |
|
2764
Futu Holdings
FUTU
$25.8B
| $466K | ﹤0.01% |
10,765
-609
| -5% | -$26.4K |
|
2765
Telesat
TSAT
$313M
| $466K | ﹤0.01% |
+16,237
| New | +$466K |
|
2766
Vuzix
VUZI
$177M
| $466K | ﹤0.01% |
53,800
| – | – |
|
|
CLDT
2767
Chatham Lodging
CLDT
$348M
| $462K | ﹤0.01% |
33,701
-2,411
| -7% | -$33.1K |
|
2768
Pathfinder Bancorp
PBHC
$92.8M
| $460K | ﹤0.01% |
26,763
+5,146
| +24% | +$88.4K |
|
2769
Capital City Bank Group
CCBG
$738M
| $459K | ﹤0.01% |
17,400
+5,056
| +41% | +$133K |
|
2770
RB Global
RBA
$21.6B
| $458K | ﹤0.01% |
7,483
+417
| +6% | +$25.5K |
|
2771
iShares Currency Hedged MSCI Japan ETF
HEWJ
$394M
| $457K | ﹤0.01% |
11,526
-32,057
| -74% | -$1.27M |
|
2772
iShares Select Dividend ETF
DVY
$20.6B
| $454K | ﹤0.01% |
3,702
+432
| +13% | +$53K |
|
|
VAPO
2773
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $454K | ﹤0.01% |
2,738
-2,028
| -43% | -$336K |
|
|
AERI
2774
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $453K | ﹤0.01% |
64,500
| – | – |
|
2775
Quanex
NX
$729M
| $452K | ﹤0.01% |
18,230
-1,557
| -8% | -$38.6K |
|